Skip to content
Search

Latest Stories

The deadline for the 2023 mandatory workforce survey closes in a week

The survey aims to provide a comprehensive picture of the community pharmacy workforce

Pharmacy owners have less than a week to complete the mandatory 2023 Community Pharmacy Workforce Survey, which closes on Sunday, December 17.


The NHS Business Services Authority sent an email with a survey link to pharmacy owners on October 23, 2023. In certain cases, such as Company Chemists’ Association member companies and other multiple pharmacy groups, head offices will centrally complete the survey.

“If you're unsure whether the survey will be completed centrally, please seek guidance from your head office,” Community Pharmacy England has said.

Since 2022, completing the annual NHS England community pharmacy workforce survey has been a Terms of Service requirement for pharmacy owners.

The survey, conducted by the North of England Commissioning Support Unit (NECS) on behalf of NHS England, includes questions about staff numbers and full-time equivalents (FTEs) for various roles, such as pharmacists, trainee pharmacists, pharmacy technicians, dispensing assistants, medicines counter assistants, and delivery drivers.

The survey also asks about any trainees in the pharmacy.

The data aims to provide a comprehensive picture of the community pharmacy workforce, identifying vacancies and regions that are particularly challenging to fill, CPE added.

This information will support decisions on how the community pharmacy workforce can contribute to clinical service expansion and ensure that education reforms benefit both pharmacists and pharmacy technicians, enabling patients to receive more services from their community pharmacies.

Data from the 2023 survey, along with the principles used for data cleansing, will be available on Community Pharmacy Workforce Survey – data.gov.uk in 2024.

The 2022 Community Pharmacy Workforce Survey revealed a 6 per cent decrease in the community pharmacy workforce, with a notable drop of 2,411 full-time equivalent pharmacists from 2021 to 2022, settling at 17,844.

Employed pharmacists decreased by 16 per cent, from 12,774 in 2021 to 10,943 in 2022, while locum pharmacists increased by 26 per cent, rising from 4,297 in 2021 to 5,477 in 2022.

Despite these changes, the total headcount of community pharmacists remained 'almost constant' between 2021 and 2022, indicating a trend of pharmacists working fewer hours in a community setting.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less